Allogene Therapeutics Alternatives & Competitors
12 companies similar to Allogene Therapeutics — A biotechnology company catalyzing cancer treatment through the development of C...
Companies similar to Allogene Therapeutics
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
Century Therapeutics, Inc
Advancing iPSC-derived cell therapies to transform care in autoimmune disease and cancer
Philadelphia, United Stat...
Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therap...
London, United Kingdom
Gracell Biotechnologies
A Member of the AstraZeneca Group
Shanghai, China
Rival Readout
Competing with Allogene Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Cartesian Therapeutics
Cartesian | Developing potent, safer cell and gene therapies for cancer and autoimmune dis...
Nkarta, Inc.
A New Way Forward for Autoimmune Disease
South San Francisco, Unit...
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
Caribou Biosciences
Clinical-stage biopharmaceutical company developing transformative therapies to treat deva...
Berkeley, United States
Repertoire Immune Medicines
Repertoire is a biotechnology company creating a new category of immune medicines for canc...
Cambridge, United States
Legend Biotech
Multinational biopharmaceutical company focused on discovering and developing cutting-edge...
Somerset, United States
Fate Therapeutics Inc.
Transforming the lives of patients with autoimmune diseases and cancer.
San Diego, United States
Adaptimmune
Designing and delivering cell therapies to transform the lives of people with cancer.
Abingdon, United Kingdom
About Allogene Therapeutics
Allogene Therapeutics, based in South San Francisco, is a clinical-stage biotechnology company spearheading the evolution of cancer treatment with its innovative AlloCAR T products. Founded in 2017, the company is at the forefront of developing allogeneic chimeric antigen receptor T cell therapies, targeting both cance...
Development of CAR T cell products, Clinical trial management, Gene editing and engineering, Manufacturing of allogeneic therapies, Therapeutic innovation for cancer and autoimmune diseases
Patients with blood cancers, Patients with solid tumors, Patients with autoimmune diseases, Healthcare providers, Biopharmaceutical partners
Clinical-stage, Cancer Treatment, Immunotherapy, CAR T Therapy, AlloCAR T Products, Allogeneic Therapies, Oncology, Autoimmune Disease, Cell Therapy, Therapy Development, Biopharmaceuticals, Medical Innovation, South San Francisco
B2B, B2C, B2D
Product Sales, Licensing, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Allogene Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Allogene Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
